Jan 29, 2018 - Pacific Biosciences (PACB) needs investors to pay close attention to the stock based on moves in the options market lately.
Jan 25, 2018 - Another big purchase order for the genome sequencing equipment manufacturer ahead of its full-year 2017 earnings report is just what investors wanted to see.
Jan 24, 2018 - Pacific Biosciences (PACB) is likely to witness year-over-year decline in product revenues.
Jan 10, 2018 - The following slide deck was published by Pacific Biosciences of California in conjunction with this event.
Jan 10, 2018 - Pacific Biosciences (PACB) faces cutthroat competition in the niche space. Also, sluggishness in the European markets is a concern.
Jan 09, 2018 - Recent publication calls into question the library preparation method commonly used for sequencing. Correcting this issue may cause short term stress and will test the company's ability to respond to
Sep 29, 2017 - Axovant is being pushed again.Gilead faces whistleblower lawsuit similar to Celgene’s.As we expected, PTCT’s Ad comm voted 10-1 against approval in present form.
Sep 06, 2017 - The following slide deck was published by Pacific Biosciences of California in conjunction with this event.
Aug 18, 2017 - The age of gene therapy approval by the FDA is upon us as investors, signaling near-term rising investor sentiment in the sector.Pacific Biosciences SMRT technology is an industry-leading genomics pla
Aug 07, 2017 - Shares of the high-accuracy genomic sequencing company continue to rise despite a lack of significant news.